投资者关系活动记录表 编号：2022-05 证券代码：301021 证券简称：英诺激光 英诺激光科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------------|--------------------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | 特定对象调研 □分析师会议 | | | 类别 | □媒体采访 □业绩说明会 | | | | □新闻发布会 | □路演活动 | | | □现场参观 | | | | □其他 电话会议 | | | 参与单位名称及 | 南方基金 | 基金经理张磊、研究员曹群海 | | 人员姓名 | 国泰君安 研究员曾大鹏 | | | 时间 2022 | 年 05 月 23 日 | | | | 地点 深圳市南山区创智云城大厦 | 1 标段 1 栋 A 座 11 层 | | 上市公司接待人 员姓名 | 董事会秘书张勇 | | | | | 会议开始前张勇先生就公司基本情况进行了介绍，现场 ...

投资者关系活动记录表 编号：2022-09 证券代码：301021 证券简称：英诺激光 英诺激光科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------------|-------------------------------------|-----------------------------------------| | 投资者关系活动 | 特定对象调研 □分析师会议 | | | 类别 | □媒体采访 □业绩说明会 | | | | □新闻发布会 | □路演活动 | | | 现场参观 | | | | 其他 电话会议 | | | 参与单位名称及 | 申万宏源：李 蕾、高楠茜； | 信达澳亚：刘国丰； | | 人员姓名 | 安信基金：曾博文； 长江证券；臧 | 雄、刘晓舟； | | | Blackrock ：杨雅童； | Pinpoint ：刘文渊； | | | WT：Brian Tang | ； 彬元资本：陈海亮； | | | 博时基金：冯圣阳； 东方红：郑华航； | | | | | 工银瑞信：谢怡婷； 光大保德信：赵志铭； | | | 国投瑞银：董政武； | ...

投资者关系活动记录表 编号：2022-07 证券代码：301021 证券简称：英诺激光 英诺激光科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------------|--------------------------|----------------------------------------------------------------------------------------------------| | | | | | 投资者关系活动 | 特定对象调研 □分析师会议 | | | 类别 | □媒体采访 □业绩说明会 | | | | □新闻发布会 | □路演活动 | | | □现场参观 | | | | 其他 电话会议 | | | | | | | 参与单位名称及 | 摩根士丹利 张 宇 | | | 人员姓名 | MCi 金成华 | | | 时间 2022 | 年 09 月 14-15 | 日 | | 地点 | 深圳市南山区创智云城大厦 | 1 标段 1 栋 A 座 11 层 | | 上市公司接待人 员姓名 | 董事会秘书张勇 | | | ...

投资者关系活动记录表 编号：2022-06 证券代码：301021 证券简称：英诺激光 英诺激光科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |-----------------------|----------------------------------|---------------|------------------------------------------------------| | | | | | | 投资者关系活动 | 特定对象调研 □分析师会议 | | | | 类别 | □媒体采访 □业绩说明会 | | | | | □新闻发布会 | □路演活动 | | | | □现场参观 | | | | | □其他 电话会议 | | | | | | | | | 参与单位名称及 | 普徕仕 T.RowePrice | 基金经理 | 郑闻立 | | 人员姓名 | 摩根资产管理 JPM | 分析师 王卓然 | | | 时间 2022 | 年 09 月 07 日 | | | | | 地点 深圳市南山区创智云城大厦 | 1 | 标段 1 栋 A 座 11 层 | ...

投资者关系活动记录表 编号：2022-08 证券代码：301021 证券简称：英诺激光 英诺激光科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-------------------------------|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系活动 | | 特定对象调研 □分析师会议 | | 类别 | | □媒体采访 □业绩说明会 | | | □新闻发布会 | □路演活动 | | | □现场参观 | | | | 其他 电话会议 | | | 参与单位名称及 | 海通证券 杨彤昕 | | | 人员姓名 | 招商基金 吴 | | | | 汇信资本 | 谷方庆、黄向阳 | | | 西部证券 李启文 | | | | 西南证券 周鑫雨 | | | | 安信证券 ...

Financial Performance - The company's revenue for Q3 2022 was ¥71,069,977.37, a decrease of 22.23% compared to the same period last year[5] - The net profit attributable to shareholders was a loss of ¥3,712,260.56, representing a decline of 114.37% year-on-year[5] - The net profit after deducting non-recurring gains and losses was a loss of ¥4,961,192.01, down 124.70% from the previous year[5] - Total operating revenue for Q3 2022 was ¥241,146,295.04, a decrease of 18.0% compared to ¥294,103,293.38 in Q3 2021[26] - Operating profit for Q3 2022 was ¥25,520,940.54, a decline of 65.2% from ¥73,461,293.23 in Q3 2021[26] - The company reported a net profit margin of approximately 10.6% for Q3 2022, down from 24.9% in Q3 2021[26] - The net profit for the third quarter was approximately ¥23.44 million, compared to ¥66.74 million in the previous year, indicating a decrease of about 64.9%[27] - The total comprehensive income for the third quarter was approximately ¥33.63 million, down from ¥66.51 million in the same period last year, a decrease of about 49.5%[27] - Basic and diluted earnings per share for the third quarter were both ¥0.1511, down from ¥0.5249 in the previous year, reflecting a decline of about 71.2%[27] Cash Flow and Investments - The operating cash flow for the year-to-date reached ¥97,021,057.28, an increase of 451.45% compared to the same period last year[5] - The operating cash flow for the third quarter was approximately ¥97.02 million, significantly higher than ¥17.59 million in the same period last year, showing an increase of about 438.5%[29] - The net cash flow from investing activities was negative at ¥-83,350,338.30, a decline of 212.20% year-on-year, attributed to increased investments in financial products and construction projects[15] - The company reported a net cash outflow from investment activities of approximately ¥83.35 million, compared to a net outflow of ¥26.70 million in the previous year[30] - The company received cash inflows from investment activities totaling approximately ¥194.73 million, with cash outflows of approximately ¥278.08 million, resulting in a net cash outflow of ¥83.35 million[30] Assets and Liabilities - Total assets at the end of Q3 2022 were ¥1,074,935,383.29, a decrease of 2.46% from the end of the previous year[5] - Cash and cash equivalents as of September 30, 2022, were ¥346,389,183.13, down from ¥359,850,342.13 at the beginning of the year[23] - Total current assets decreased to ¥800,328,622.16 from ¥832,771,985.75 at the start of the year, reflecting a decline of 3.9%[23] - Total liabilities decreased to ¥82,657,555.34 from ¥126,352,506.21, indicating a reduction of 34.6%[24] - Total equity attributable to shareholders increased to ¥989,436,374.07 from ¥973,798,039.73, showing a growth of 1.6%[24] Shareholder Information - The top 10 shareholders hold significant stakes, with DeTai International Investment Group owning 28.10% (42,580,000 shares) and Shenzhen Hongcui Investment Enterprise holding 25.72% (38,970,000 shares) [18] - The company reported a total of 117,445,082 restricted shares at the beginning of the period, with 35,895,082 shares released, leaving 81,550,000 restricted shares at the end of the period [20] - The company has a diverse shareholder base, including both domestic and foreign entities, with the largest shareholder being a foreign legal entity [18] - The company has not disclosed any known relationships or concerted actions among its shareholders, except for one natural person shareholder who is a partner in another investment entity [19] - The company has a total of 10,030,000 unrestricted shares held by Shenzhen Huishang Investment Enterprise, which is the largest among the unrestricted shareholders [20] - The company has a total of 3,800,000 shares held under a collective asset management plan by Great Wall Securities and China Construction Bank [20] Research and Development - Research and development expenses for Q3 2022 were ¥41,799,096.18, an increase of 9.0% compared to ¥38,093,325.71 in Q3 2021[26] - The company has not reported any new product developments or technological advancements in this quarter [22] - The company plans to focus on market expansion and new product development in the upcoming quarters[25] Market Strategy and Outlook - There are no significant market expansion or acquisition strategies mentioned in the report [22] - The company has not provided specific future outlook or performance guidance in this report [22] Other Comprehensive Income - The company reported a significant increase of 1666.29% in other comprehensive income, totaling ¥9,581,695.98, due to the appreciation of the US dollar[10] - The other comprehensive income attributable to the parent company was approximately ¥9.79 million, compared to a loss of ¥0.21 million in the previous year, indicating a significant improvement[27]

Financial Performance - The company reported a revenue of RMB 100 million for the first half of 2022, representing a year-on-year increase of 20%[20] - The gross profit margin for the first half of 2022 was 45%, compared to 40% in the same period last year[20] - The company's operating revenue for the reporting period was ¥170,076,317.67, a decrease of 16.10% compared to the same period last year[27] - The net profit attributable to shareholders was ¥26,623,025.64, down 34.20% year-on-year[27] - The net profit after deducting non-recurring gains and losses was ¥17,094,392.67, reflecting a decline of 35.04% compared to the previous year[27] - The net cash flow from operating activities increased significantly to ¥67,011,917.99, a rise of 7,437.92% from the previous year[27] - The company achieved operating revenue of 170.08 million yuan, a year-on-year decrease of 16.10%[68] - The net profit attributable to shareholders was 26.62 million yuan, down 34.20% year-on-year[60] - The total comprehensive income for the first half of 2022 was CNY 32,191,968.75, down from CNY 41,543,519.00 in the same period of 2021[193] Market Expansion and Strategy - The company plans to invest RMB 50 million in R&D for new laser technologies in the upcoming year[20] - User data indicates a 30% increase in active users of the company's laser products compared to the previous year[20] - The company is expanding its market presence in Southeast Asia, aiming for a 15% market share by the end of 2023[20] - The company is focusing on expanding its market presence in the biomedical field, leveraging its core technologies in laser applications[64] - The company is expanding its market presence in the micro-processing and new energy sectors, with a focus on high-quality development[102] - The company is actively developing new products, including laser equipment for medical applications[107] Research and Development - The company focuses on the R&D, production, and sales of laser devices and embedded laser modules, serving various industries including consumer electronics and biomedical[35] - The company has established R&D centers in both China and the United States, enhancing its technological innovation capabilities and maintaining competitiveness in core technologies[40] - Research and development expenses increased by 6.14% year-on-year, totaling 27.16 million yuan[68] - The company applied for a total of 25 intellectual property rights during the reporting period, including 13 invention patents[63] - The establishment of a joint laboratory for photoacoustic imaging was completed, enhancing product clinical transformation capabilities[65] Financial Position and Assets - The total assets at the end of the reporting period were ¥1,089,758,646.35, a decrease of 1.12% from the end of the previous year[27] - The net assets attributable to shareholders increased to ¥989,950,902.45, marking a growth of 1.66% compared to the previous year[27] - Cash and cash equivalents decreased to CNY 249,897,038, down 9.72% from CNY 359,850,342 at the end of the previous year[75] - The company’s inventory stood at CNY 173,483,506, a slight decrease of 0.27% compared to CNY 178,465,296 at the end of the previous year[75] - The company reported a significant increase in trading financial assets, rising to ¥195,262,805.47 from ¥47,050,924.71, representing a growth of approximately 315.5%[184] Risks and Challenges - The company faces risks related to supply chain disruptions and is implementing strategies to mitigate these risks[4] - The company faces risks from macroeconomic uncertainties, including global political and economic factors, which may impact industry demand and costs[102] - To address competition risks, the company plans to optimize product design and leverage brand advantages to maintain a high gross margin[104] - The company is focused on innovation-driven development to mitigate management risks associated with scaling operations[105] Shareholder and Corporate Governance - No cash dividends or stock bonuses will be distributed to shareholders for the current fiscal year[5] - The company plans not to distribute cash dividends or issue bonus shares for the half-year period[112] - A stock incentive plan was approved, granting a total of 3 million restricted stocks, representing 1.98% of the company's total share capital[114] - The company has not engaged in any related party transactions during the reporting period, including asset or equity acquisitions or joint investments[134][135] - The company has confirmed that there are no violations in the management of raised funds and all related information has been disclosed accurately and completely[93] Corporate Social Responsibility - The company emphasizes its commitment to social responsibility and aims to balance economic, environmental, and social factors[119] - The company has not experienced any significant environmental penalties during the reporting period[118] Investor Relations - The company conducted multiple investor communications to discuss its strategic direction and financial performance[107] - The company held its first temporary shareholders' meeting on April 8, 2022, with an investor participation rate of 14.60%[110] - The annual shareholders' meeting on May 13, 2022, had a participation rate of 60.69%[110] - The second temporary shareholders' meeting on June 1, 2022, saw a participation rate of 53.79%[110]

Revenue and Profitability - Revenue for Q1 2022 was CNY 80,498,706.84, a decrease of 6.49% compared to CNY 86,081,994.81 in the same period last year[4] - Net profit attributable to shareholders was CNY 12,394,501.00, down 36.64% from CNY 19,562,925.67 year-over-year[4] - Basic earnings per share decreased by 52.53% to CNY 0.0817 from CNY 0.1721 in the previous year[4] - Total operating revenue for Q1 2022 was CNY 80,498,706.84, a decrease of 6.1% compared to CNY 86,081,994.81 in the same period last year[25] - Net profit for Q1 2022 was CNY 13,177,021.23, a decline of 36.5% compared to CNY 20,856,576.52 in Q1 2021[27] - The company's gross profit margin for Q1 2022 was approximately 20.1%, compared to 22.5% in the previous year[25] - The company reported a comprehensive income of CNY 12,795,350.23 for Q1 2022, compared to CNY 21,445,131.21 in the same period last year[27] Cash Flow - Net cash flow from operating activities increased significantly by 715.88% to CNY 36,022,107.70, compared to a negative cash flow of CNY -5,848,870.48 in the same period last year[4] - The net cash flow from operating activities was ¥36,022,107.70, a significant improvement compared to a net outflow of ¥5,848,870.48 in the previous period[29] - Total cash inflow from operating activities amounted to ¥118,694,498.59, up from ¥81,846,384.61 in the prior period, reflecting a growth of approximately 45%[29] - Cash outflow from operating activities decreased to ¥82,672,390.89 from ¥87,695,255.09, indicating a reduction of about 5%[29] - The net cash flow from investment activities was -¥145,188,347.79, compared to -¥14,388,363.28 in the previous period, showing a substantial increase in cash outflow[30] - Cash inflow from investment activities totaled ¥40,447,731.48, while cash outflow reached ¥185,636,079.27, resulting in a negative cash flow from investments[30] - The net cash flow from financing activities was -¥496,017.55, a decrease from -¥41,985,830.24 in the previous period, indicating improved cash management[30] - The company received ¥40,000,000.00 from borrowings during the financing activities, which was a significant source of cash inflow[30] - The company reported a cash outflow of ¥85,450,000.00 for debt repayment, highlighting its commitment to managing liabilities[30] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,098,994,866.41, a slight decrease of 0.28% from CNY 1,102,062,134.78 at the end of the previous year[4] - The total assets as of the end of Q1 2022 were CNY 1,098,994,866.41, a slight decrease from CNY 1,102,062,134.78 at the end of the previous quarter[24] - Total liabilities decreased to CNY 110,505,409.68 in Q1 2022 from CNY 126,352,506.21 in the previous quarter[24] - The company's cash and cash equivalents at the end of the period amount to ¥245,326,266.63, down from ¥359,850,342.13 at the beginning of the year[22] - The company's cash and cash equivalents were CNY 827,757,397.79, showing a minor decrease from CNY 832,771,985.75 in the previous quarter[24] Shareholder Information - Total number of common shareholders at the end of the reporting period is 15,232[16] - The largest shareholder, DeTai International Investment Group Limited, holds 28.08% of shares, totaling 42,580,000 shares[16] - The second largest shareholder, Shenzhen Hongcui Investment Enterprise (Limited Partnership), holds 25.70% of shares, totaling 38,970,000 shares[16] - The company has a total of 119,217,416 shares subject to lock-up agreements, with 1,772,334 shares released during the period[20] - The company plans to release the lock-up on shares held by major shareholders on July 6, 2022[19] Expenses and Investments - The company’s sales expenses decreased by 42.22% to CNY 3,990,227.68, attributed to reduced promotional activities due to the pandemic[12] - Research and development expenses for Q1 2022 were CNY 11,790,554.10, slightly down from CNY 12,059,703.98 in the same quarter last year[25] - Investment income for the period was CNY 461,018.33, primarily from the maturity of structured deposits[12] Financial Reporting - The report for the first quarter was not audited, which may affect the reliability of the financial data presented[31] - The company has not disclosed any significant new strategies or product developments during the reporting period[21]

Financial Performance - The company's revenue for Q1 2022 was ¥80,498,706.84, a decrease of 6.49% compared to ¥86,081,994.81 in the same period last year[4] - Net profit attributable to shareholders was ¥12,394,501.00, down 36.64% from ¥19,562,925.67 year-on-year[4] - Basic and diluted earnings per share were both ¥0.1091, reflecting a decline of 36.61% compared to ¥0.1721 in the same period last year[4] - Total operating revenue for Q1 2022 was CNY 80,498,706.84, a decrease of 6.1% compared to CNY 86,081,994.81 in Q1 2021[24] - Net profit for Q1 2022 was CNY 13,177,021.23, a decline of 36.5% from CNY 20,856,576.52 in Q1 2021[26] - The company's gross profit margin for Q1 2022 was approximately 20.2%, compared to 22.5% in Q1 2021[24] - The company reported a comprehensive income total of CNY 12,795,350.23 for Q1 2022, compared to CNY 21,445,131.21 in the same period last year, indicating a significant decline[26] Cash Flow - The net cash flow from operating activities increased significantly to ¥36,022,107.70, a 715.88% improvement from -¥5,848,870.48 in the previous year[4] - Cash inflow from operating activities totaled CNY 118,694,498.59, compared to CNY 81,846,384.61 in the prior period, reflecting a growth of approximately 45%[28] - Cash outflow from operating activities decreased to CNY 82,672,390.89 from CNY 87,695,255.09, indicating a reduction of about 6%[28] - The net cash flow from investing activities was -¥145,188,347.79, a 909.07% decline compared to -¥14,388,363.28 in the previous year, mainly due to the purchase of structured deposits[14] - The net cash flow from investing activities was negative CNY 145,188,347.79, worsening from a negative CNY 14,388,363.28 in the previous period[30] - Total cash inflow from investing activities was CNY 40,447,731.48, while cash outflow reached CNY 185,636,079.27, resulting in a net outflow[30] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,098,994,866.41, a slight decrease of 0.28% from ¥1,102,062,134.78 at the end of the previous year[4] - Total liabilities decreased to CNY 110,505,409.68 in Q1 2022 from CNY 126,352,506.21 in Q1 2021, reflecting a reduction of 12.6%[23] - The company's cash and cash equivalents at the end of the period amount to ¥245,326,266.63, down from ¥359,850,342.13 at the beginning of the year[21] - The company's cash and cash equivalents were CNY 827,757,397.79, showing a marginal decrease from CNY 832,771,985.75 in the previous year[23] Shareholder Information - Total number of common shareholders at the end of the reporting period is 15,232[16] - The largest shareholder, DeTai International Investment Group Limited, holds 28.08% of shares, totaling 42,580,000 shares[16] - The second-largest shareholder, Shenzhen Hongcui Investment Enterprise, holds 25.70% of shares, totaling 38,970,000 shares[16] Inventory and Receivables - The company experienced a 65.40% increase in accounts payable, reaching ¥43,056,656.00, attributed to increased inventory levels[9] - Accounts receivable decreased to ¥123,159,511.79 from ¥142,649,607.32, a decline of 13.7%[21] - Inventory at the end of the period is ¥179,034,201.34, slightly up from ¥178,465,296.24[21] Research and Development - Research and development expenses for Q1 2022 were CNY 11,790,554.10, slightly down from CNY 12,059,703.98 in the same period last year[24] Other Information - The company received government subsidies amounting to ¥1,275,130.57 during the reporting period[7] - The company has not disclosed any new product developments or market expansion strategies in the current report[20] - The first quarter report was not audited, indicating that the figures presented are preliminary and subject to change[31] - The company plans to release restricted shares totaling 119,217,416, with a significant portion set to be released on July 6, 2022[19] - The company has a total of 1,772,334 shares that will be released from restrictions on January 6, 2022[19]

Financial Performance - The company's operating revenue for 2021 was ¥390,976,202.73, representing a 15.32% increase compared to ¥339,048,930.36 in 2020[19]. - The net profit attributable to shareholders for 2021 was ¥74,909,120.89, up 14.24% from ¥65,573,305.53 in 2020[19]. - The company's total revenue for 2021 was ¥390,976,202.73, representing a year-on-year increase of 15.32% compared to ¥339,048,930.36 in 2020[86]. - The net cash flow from operating activities decreased by 62.39% to ¥25,347,886.34 in 2021 from ¥67,392,115.84 in 2020[19]. - The company reported a basic earnings per share of ¥0.5647 for 2021, a decrease of 2.13% from ¥0.5770 in 2020[19]. - The company achieved a revenue of 390.98 million yuan in 2021, representing a year-on-year growth of 15.32%[66]. - The net profit attributable to shareholders was 74.91 million yuan, with a year-on-year increase of 14.24%[66]. - The company reported a total revenue of 1.5 billion RMB for the fiscal year 2021, representing a year-over-year growth of 20%[168]. Dividend Distribution - The company plans to distribute a cash dividend of 1.20 RMB per 10 shares to all shareholders, based on a total of 151,645,082 shares[4]. - The company has a total of 151,645,082 shares outstanding, which serves as the basis for its profit distribution plan[4]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements in the report, highlighting potential operational risks and corresponding mitigation strategies[4]. - The company anticipates risks from macroeconomic uncertainties and intensified industry competition, and it plans to adopt strategies to mitigate these risks[140][141]. - The company is addressing risks associated with product price declines through effective cost management and supply chain strategies[145]. Research and Development - The company applied for 55 intellectual property rights in 2021, including 15 invention patents and 20 utility model patents[71]. - The company has established R&D centers in both North America and China, enhancing its technological capabilities and market responsiveness[62]. - The company is focusing on technological innovation and collaboration between its innovation center and North American R&D center to stay ahead in the market[137][138]. - The R&D expenditure for 2021 was 200 million RMB, accounting for 13.3% of total revenue, aimed at enhancing product innovation[168]. - The company has restructured its R&D functions in North America and domestically to enhance its technological capabilities and product development[101]. Market Position and Strategy - The company is a leading domestic manufacturer of micro-processing lasers and the first listed company in this sector, possessing core technologies for nanosecond, sub-nanosecond, picosecond, and femtosecond micro-processing lasers[41]. - The company aims to enhance its market share in the laser industry and expand its presence in the US market, focusing on sectors like new energy, semiconductors, and biomedicine[135]. - The company is committed to becoming a global leader in laser solutions, with a mission to benefit humanity through laser technology[131][132]. - The company is actively exploring new application areas for its laser products, which are expected to drive future growth[147]. Subsidiaries and Operations - The company has a full subsidiary named Shenzhen Yingwei Intelligent Technology Co., Ltd.[12]. - The company has a full subsidiary named Jiangsu Weina Laser Application Technology Research Institute Co., Ltd.[12]. - The company has a full subsidiary named Advanced Optowave Corporation in the United States[12]. - The company maintains a direct sales model, with domestic sales managed by its subsidiary in Changzhou and international sales primarily through its overseas subsidiary AOC[48]. Corporate Governance - The company strictly adheres to regulations and continuously improves its corporate governance structure, ensuring compliance with relevant laws and guidelines[150]. - The company has 7 board members, including 3 independent directors, who actively participate in training and decision-making processes[152]. - The company maintains complete independence from its controlling shareholder, with no guarantees or non-operational fund occupation reported during the reporting period[151]. - The company has established an independent financial department with a complete financial accounting system, ensuring independent financial decision-making[161]. Employee and Management - The total number of employees at the end of the reporting period was 361, with 84 in the parent company and 277 in major subsidiaries[198]. - The professional composition included 164 production personnel, 32 sales personnel, 112 technical personnel, 12 financial personnel, and 41 administrative personnel[198]. - The company conducts regular training needs assessments and develops annual training plans to enhance employee skills[200]. - The company has a diverse management team with experience in various sectors, including finance and technology[185]. Financial Position - Cash and cash equivalents increased by 473.17% to ¥164,160,549.38, reflecting a significant inflow from financing activities[103]. - The company raised CNY 359,480,000.00 through its IPO, with a net amount of CNY 308,463,526.34 after deducting issuance costs[117]. - The balance of the fundraising account as of December 31, 2021, was RMB 158,470,764.73, with a discrepancy of RMB 1,059,195.25 attributed to bank interest and financial product income[119]. - The company has established a complete asset control system, independent of its controlling shareholder[158].